Myofascial Pain - Dysfunction Syndrome of TMJ
6
0
0
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Bruxism, Pelvic Pain, Erectile Dysfunction, and Anxiety in Young Adult Men
Efficiency of Botulinum Toxin type-a in the Management of the Myofascial Pain
Evaluation of the Effect of Occlusal Splint Use on Masticatory Muscles
Dry Needling Vs Transcutaneous Electrical Nerve Stimulation in Management of Myofascial Pain Dysfunction Syndrome
Comparison of Therapeutic Effects of Trigger Point Injection and Twin Nerve Block in Chronic Myofascial Pain Patients
Is Masseteric Nerve Block Effective in Myofascial Pain